Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2022 08:30 ET | Source: Zylö Therapeutics

Zylö Receives $263,000 NIH Phase I Grant to Develop a Topical Viagra® for ED

Funds to be used to optimize a formulation and demonstrate comparable efficacy to oral Viagra GREENVILLE, SC, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod®...
November 10, 2021 09:00 ET | Source: Zylö Therapeutics

Zylö’s Erectile Dysfunction Product Concept Wins Best Abstract Award

The product concept uses patent-pending Z-pods™ to sustainably—for over an hour—release nitric oxide GREENVILLE, SC, Nov. 10, 2021 (GLOBE NEWSWIRE) -- A novel nitric-oxide-releasing product concept...
July 20, 2021 09:00 ET | Source: Zylö Therapeutics

Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

Funds to be used for scale-up, implementation of cGMP quality system, and pre-IND FDA meeting GREENVILLE, SC, July 20, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the...